Agios Pharmaceuticals Inc Revenu Q/Q
Quel est le Revenu Q/Q de Agios Pharmaceuticals Inc?
Le Revenu Q/Q de Agios Pharmaceuticals Inc est 28.35%
Quelle est la définition de Revenu Q/Q?
La croissance trimestrielle du chiffre d'affaires, d'une année sur l'autre , correspond à l'augmentation du chiffre d'affaires d'une entreprise par rapport à la performance du trimestre correspondant d'un exercice précédent, exprimée en pourcentage.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenu Q/Q des entreprises dans Health Care secteur sur NASDAQ par rapport à Agios Pharmaceuticals Inc
Que fait Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Entreprises avec revenu q/q similaire à Agios Pharmaceuticals Inc
- MACOM Technology Solutions Inc a Revenu Q/Q de 28.25%
- Entertainment Network (India) a Revenu Q/Q de 28.25%
- IPH a Revenu Q/Q de 28.26%
- Freshpet Inc a Revenu Q/Q de 28.32%
- Surgical Innovations plc a Revenu Q/Q de 28.33%
- Chevalier International a Revenu Q/Q de 28.34%
- Agios Pharmaceuticals Inc a Revenu Q/Q de 28.35%
- Plover Bay Technologies a Revenu Q/Q de 28.36%
- Gokaldas Exports a Revenu Q/Q de 28.37%
- RingCentral a Revenu Q/Q de 28.38%
- MidWestOne Inc a Revenu Q/Q de 28.39%
- Larsen & Toubro Infotech a Revenu Q/Q de 28.40%
- Chaowei Power a Revenu Q/Q de 28.40%